MedPath

The effect of fourteen days regimen of four medications bismuthe subcirate, pantoprazole, amoxicilline, clarithromycin” and seven days sequential regimen of bismuthe subcirate, pantoprazole, amoxicilline, meteronidazole” and bismuthe subcirate, pantoprazole, amoxicilline, furazolidone” in helicobacter pylori eradicatio

Phase 3
Conditions
Helicobacter pylori.
Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Registration Number
IRCT201708071155N26
Lead Sponsor
Guilan Univercity of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
344
Inclusion Criteria

• Positive helicobacter pylori in the endoscopy and no therapeutic regimen for treatment
•Exclusion criteria: Pregnant and breast feeding women, gastric and esophageal malignancy, cirrhosis, heart and kidney failure, history of seizure, hematologic diseases, and allergy to medications, patients with incomplete treatment period, severe side effects, and no satisfaction to continue treatment

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Helicobacter pylori eradication. Timepoint: 12 weeks. Method of measurement: Ureas Breath Test with C14.
Secondary Outcome Measures
NameTimeMethod
Comparison of helicobacter pylori eradication of fourteen days regimen of four medications bismuthe subcirate, pantoprazole, amoxicilline, clarithromycin” with seven days sequential regimen of bismuthe subcirate, pantoprazole, amoxicilline, meteronidazole” and bismuthe subcirate, pantoprazole, amoxicilline, furazolidone”. Timepoint: 2-4 weeks. Method of measurement: 2-4 weeks.
© Copyright 2025. All Rights Reserved by MedPath